International Journal of Medical Sciences

Impact factor
2.284

13 November 2018

ISSN 1449-1907 News feeds of published articles

Manuscript login | Account

open access Global reach, higher impact

Journal of Genomics in PubMed Central. Submit manuscript now...

Theranostics

Journal of Cancer

International Journal of Biological Sciences

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Oncomedicine

Journal of Biomedicine

Nanotheranostics

PubMed Central Indexed in Journal Impact Factor

Int J Med Sci 2018; 15(8):782-787. doi:10.7150/ijms.24755

Review

Hyperbaric Oxygen Therapy in Liver Diseases

Yun Sun1,2*, Yankai Wen3,4*, Chanjuan Shen1,2*, Yuanrun Zhu5, Wendong You5, Yuanyuan Meng6, Lijuan Chen1,2, Yiping Feng1,2, Xiaofeng Yang5, Zuo-Bing Chen1,2✉

1. Department of Rehabilitation Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
2. Department of Hyperbaric Oxygen, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
3. School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
4. Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
5. Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
6. Department of Pediatric Medicine, The Children's Hospital, Zhejiang University, Hangzhou, China.
* These authors contribute equally to this work.

Abstract

Hyperbaric oxygen therapy (HBOT) is an efficient therapeutic option to improve progress of lots of diseases especially hypoxia-related injuries, and has been clinically established as a wide-used therapy for patients with carbon monoxide poisoning, decompression sickness, arterial gas embolism, problematic wound, and so on. In the liver, most studies positively evaluated HBOT as a potential therapeutic option for liver transplantation, acute liver injury, nonalcoholic steatohepatitis, fibrosis and cancer, especially for hepatic artery thrombosis. This might mainly attribute to the anti-oxidation and anti-inflammation of HBOT. However, some controversies are existed, possibly due to hyperbaric oxygen toxicity. This review summarizes the current understandings of the role of HBOT in liver diseases and hepatic regeneration. Future understanding of HBOT in clinical trials and its in-depth mechanisms may contribute to the development of this novel adjuvant strategy for clinical therapy of liver diseases.

Keywords: hyperbaric oxygen, liver diseases, toxicity

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Sun Y, Wen Y, Shen C, Zhu Y, You W, Meng Y, Chen L, Feng Y, Yang X, Chen ZB. Hyperbaric Oxygen Therapy in Liver Diseases. Int J Med Sci 2018; 15(8):782-787. doi:10.7150/ijms.24755. Available from http://www.medsci.org/v15p0782.htm